We discovered that high ACE2 expression was correlated with the enhanced response to immunotherapy by checking the difference of immune checkpoints expressions, T cell inflamed score, TMB, MMR protein deficiency status and IPS scores in the high and low ACE2 groups. The gene discussed is ACE2; the disease is hereditary thrombophilia due to congenital protein S deficiency.